| Deep learning with radiomics for disease diagnosis and treatment: challenges and potential X Zhang, Y Zhang, G Zhang, X Qiu, W Tan, X Yin, L Liao Frontiers in oncology 12, 773840, 2022 | 119 | 2022 |
| Radiomics under 2D regions, 3D regions, and peritumoral regions reveal tumor heterogeneity in non-small cell lung cancer: a multicenter study X Zhang, G Zhang, X Qiu, J Yin, W Tan, X Yin, H Yang, L Liao, H Wang, ... La radiologia medica 128 (9), 1079-1092, 2023 | 17 | 2023 |
| Prospective clinical research of radiomics and deep learning in oncology: A translational review X Zhang, Y Zhang, G Zhang, X Qiu, W Tan, X Yin, L Liao Critical Reviews in Oncology/Hematology 179, 103823, 2022 | 13 | 2022 |
| Exploring non-invasive precision treatment in non-small cell lung cancer patients through deep learning radiomics across imaging features and molecular phenotypes X Zhang, G Zhang, X Qiu, J Yin, W Tan, X Yin, H Yang, H Wang, Y Zhang Biomarker Research 12 (1), 12, 2024 | 7 | 2024 |
| Non-invasive decision support for clinical treatment of non-small cell lung cancer using a multiscale radiomics approach X Zhang, G Zhang, X Qiu, J Yin, W Tan, X Yin, H Yang, H Wang, Y Zhang Radiotherapy and Oncology 191, 110082, 2024 | 5 | 2024 |
| Optimizing the Size of Peritumoral Region for Assessing Non-Small Cell Lung Cancer Heterogeneity Using Radiomics X Zhang, G Zhang, X Qiu, J Yin, W Tan, X Yin, H Yang, K Wang, Y Zhang International Conference on Health Information Science, 309-320, 2023 | 3 | 2023 |
| Evaluation of EGFR-TKIs and ICIs treatment stratification in non-small cell lung cancer using an encrypted multidimensional radiomics approach X Zhang, X Qiu, Y Zhang, Q Lai, Y Zhang, G Zhang Cancer Imaging 25 (1), 3, 2025 | | 2025 |
| Check for updates Optimizing the Size of Peritumoral Region for Assessing Non-Small Cell Lung Cancer Heterogeneity Using Radiomics X Zhang, G Zhang, X Qiu, J Yin¹, W Tan, X Yin¹, H Yang¹, K Wang, ... Health Information Science: 12th International Conference, HIS 2023 …, 2023 | | 2023 |
| Successful neoadjuvant treatment of EGFR exon 19 deletion combined with TP53 mutation in non-small cell lung cancer using aumolertinib after osimertinib-induced myocardial … G Zhang, X Tang, X Zhang, X Qiu, Q Lai, J Li Anti-Cancer Drugs 34 (8), 954-961, 2023 | | 2023 |
Wenjun TanNortheastern Universitymail.neu.edu.cn의 이메일 확인됨
